BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38069915)

  • 21. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort.
    Welsh P; Kimenai DM; Marioni RE; Hayward C; Campbell A; Porteous D; Mills NL; O'Rahilly S; Sattar N
    Clin Chem Lab Med; 2022 Oct; 60(11):1820-1829. PubMed ID: 35976089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of GDF-15, hs-cTnT and NT-proBNP with coronary artery disease in patients undergoing elective angiography.
    Souaid T; Hijazi Z; Barakett V; Sarkis A; Kadri Z; Batra G; Lindbäck J; Abdelmassih T; Azar RR
    Future Cardiol; 2022 Aug; 18(8):635-646. PubMed ID: 35678322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
    Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
    ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial.
    Hjort M; Eggers KM; Lakic TG; Lindbäck J; Budaj A; Cornel JH; Giannitsis E; Katus HA; Siegbahn A; Storey RF; Becker RC; Wallentin L; Lindahl B;
    J Am Heart Assoc; 2023 Jan; 12(1):e027466. PubMed ID: 36565198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
    Welsh P; Doolin O; Willeit P; Packard C; Macfarlane P; Cobbe S; Gudnason V; Di Angelantonio E; Ford I; Sattar N
    Eur Heart J; 2013 Feb; 34(6):443-50. PubMed ID: 22942340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
    Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
    Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
    [No Abstract]   [Full Text] [Related]  

  • 30. Prediction of perioperative cardiac events through preoperative NT-pro-BNP and cTnI after emergent non-cardiac surgery in elderly patients.
    Ma J; Xin Q; Wang X; Gao M; Wang Y; Liu J
    PLoS One; 2015; 10(3):e0121306. PubMed ID: 25799524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
    Chen JR; Wang Q; Wu W; Zhang SJ
    Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control.
    Jacobsen DP; Røysland R; Strand H; Moe K; Sugulle M; Omland T; Staff AC
    Acta Diabetol; 2022 Sep; 59(9):1229-1236. PubMed ID: 35796791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
    Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
    ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
    Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
    JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
    Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
    Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.